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Case Report 
Tuberculous Aortic Pseudoaneurysm Treated with 
In Situ Silver-impregnated Vascular Inlay Graft
Hanif Hussein and Zainal A. Azizi, Vascular Unit, Department of Surgery, Hospital Kuala Lumpur, 
Kuala Lumpur, Malaysia.
A 62-year-old man presented with continuous, persistent backache shortly after completion of anti-
tuberculosis medication for tuberculosis (TB) of the spine. Computed tomography scan revealed a
pseudoaneurysm involving the infrarenal aorta. He was restarted on anti-TB medication and underwent
repair of the pseudoaneurysm with an in situ silver-coated bifurcated Dacron graft. His postoperative
recovery was uneventful and he remained well up to 12 months of follow up. To our knowledge, this is
the first case in the literature where an in situ silver-impregnated vascular graft has been successfully used
in treating a tuberculous pseudoaneurysm. [Asian J Surg 2008;31(2):87–9]
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Case report
A 62-year-old male was referred for the management of
continuous, persistent backache associated with a tender,
pulsatile and expansile central abdominal mass. Twelve
months prior to this, he was diagnosed with tuberculosis
(TB) of the spine and was treated with anti-TB medica-
tions with open drainage and internal fixation.
Physical examination was unremarkable apart from
the pulsatile and expansile central abdominal mass. The
peripheral pulses were noted to be palpable. Computed
tomography (CT) scan and magnetic resonance angiogra-
phy of the abdomen revealed an infrarenal aortic pseudo-
aneurysm (Figures 1 and 2). Chest radiography showed
normal lung fields with no features of pulmonary TB. His
C-reactive protein and erythrocyte sedimentation rate
were elevated at 8.31 mg/dL and 70 mm/hr respectively.
Sputum for acid-fast bacilli (AFB) was negative. A presump-
tive diagnosis of tuberculous aortic pseudoaneurysm was
made. His anti-TB medications were restarted and he was
scheduled for surgery.
A right axillounifemoral bypass was performed using
an 8-mm Advanta VS externally supported polytetrafluo-
roethylene graft with slider (Atrium Medical Corporation,
Hudson, NH, USA). This was followed by laparotomy
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Figure 1. Sagittal computed tomography shows the aortic
pseudoaneurysm (a) with extension of the sac to the adjacent
psoas muscles bilaterally (b).
through a midline incision. At surgery, there was a 6-cm
pseudoaneurysm arising from the infrarenal aorta extend-
ing down to the distal aorta before its bifurcation. The sac
was inflamed but there was no pus or any caseation of the
sac wall. There was a defect in the posterior wall of the sac
with clots in both adjacent psoas muscles. A 16 × 8 mm
bifurcated silver-impregnated Dacron graft (B. Braun
Medical Inc., Bethlehem, PA, USA) was anastomosed to
the infrarenal aorta proximally and to the external iliac
arteries distally. Upon release of the clamps, the left femoral
pulse was noted to be weak. This was thought to be due to
vessel damage during clamping of the calcified left common
iliac artery. The left groin was then explored, and a jump
graft from the left limb of the aortic graft to the left common
femoral artery was carried out following failed attempts to
establish good inflow with a Fogerty embolectomy catheter.
Perfusion to the left lower limb was then re-established.
Postoperative recovery was uneventful. The culture 
of the sac wall and clots were negative for aerobic and
anaerobic organisms but was not cultured for AFB. He
was maintained on biweekly isoniazide, rifampicin and
pyridoxine for another 6 months. He was seen on follow-up
at 2 monthly intervals. On his latest follow-up at 12 months
after surgery, he was noted to be well with no signs of 
re-infection.
Discussion
TB is still a common disease in Malaysia and around the
world. There is a worldwide resurgence of the disease due
to drug-resistant TB in association with acquired immu-
nodeficiency syndrome. It poses a great concern among 
clinicians as it can mimic many diseases in its presenta-
tion. Extrapulmonary involvement is rather common but
involvement of the aorta is rare worldwide, and has 
not been reported in Malaysia.1 Tuberculous pseudo-
aneurysm can present with free intraperitoneal rupture of
the aneurysm, or as upper or lower gastrointestinal (GI)
bleeding due to fistulation to the GI tract, usually the
duodenum.2 Involvement of the thoracic aorta can fis-
tulate to the bronchus causing massive haemoptysis.3
It may also present with symptoms of any atherosclerotic
aortic aneurysm with persistent back pain or pulsatile
abdominal mass. There may not be any history of pul-
monary TB or any significant pulmonary findings. Long
et al has suggested that tuberculous aortic aneurysm
should be suspected in the presence of one of three clini-
cal scenarios, which are persistent pain, major bleeding
and palpable or radiologically visible para-aortic mass.1
As suggested by Long et al, this department adopts the
policy that treatment for TB patients should be started
empirically based on a high index of suspicion while await-
ing specific investigations. Staining for AFB may not always
be positive and culture for mycobacterium is not routinely
done here due to the prolonged incubation period. In a
retrospective study of extrapulmonary TB in the Malaysian
Peninsula, Nissapatorn et al noted that histopathology,
being the most used diagnostic tool, was used in only half
the patients to diagnose TB.4
As an aneurysm is inflammatory in nature, the mor-
phology of tuberculous aneurysm is more likely to be sac-
cular rather than fusiform, and also a pseudo rather than
a true aneurysm.1 Both of these factors increase the risk
of rupture of the aneurysm and other possible complica-
tions, as compared to an atherosclerotic aortic aneurysm.
Early initiation of treatment is therefore important for a
better outcome. This again emphasizes the necessity for
empirical treatment based on a high index of suspicion of
the disease while awaiting specific investigations.
Surgical intervention is unavoidable due to the natu-
ral outcome of an aneurysm and early intervention is
advocated due to the low threshold for rupture of an
inflammatory or pseudoaneurysm. In the review by Long
et al, patients with both surgical and medical therapy fared
much better than those who had either therapy alone.
There were no survivors among the patients who received
only one modality of treatment.1 Pharmacotherapy with
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Figure 2. Magnetic resonance imaging shows the aortic pseudo-
aneurysm eroding into the vertebral column (a).
standard anti-TB treatment is initiated once diagnosis is
made or suspected and continued for at least 6 months
after surgery. Surgical intervention may be in the form 
of in situ graft implantation or aneurysm exclusion with
extra-anatomical revascularization of the lower limbs.
Successful surgical treatment with interposition grafts
has been reported.5 Endovascular exclusion of a tubercu-
lous aneurysm is another option and this has also been
reported in the literature.6 This option was, however, not
considered in this patient as we had just started our
endovascular aneurysm repair services.
Temporary axillofemoral bypass has been described in
high risk patients and patients with transplanted kidneys
going for aneurysm repair.7,8 We opted to perform an axil-
lounifemoral bypass in this patient as an initial procedure.
This allows reduction of the cardiac afterload and at the
same time perfusion of the lower limbs during aortic cross
clamping, which we expected to be longer. However, the
main concern that prompted us to perform this bypass
was the possibility of infection and not being able to do
an in situ graft implantation. In such a situation, the sac
would be excluded and the aorta ligated proximally below
the renal arteries. If the distal aorta needed to be ligated
beyond its bifurcation, then a femoral-femoral crossover
graft would be necessary to perfuse the contralateral limb.
Silver is currently used as an active substance in many
dressing preparations for its wide-spectrum antimicrobial
properties, including some resistant strains.9 Its use has
now been extended to vascular prosthesis as prophylaxis
in cases with high risk of graft infection. The French
InterGard Silver (IGS) Study Group reported a low graft
infection rate despite a high nosocomial infection rate
with the use of silver vascular prosthesis in 289 patients.10
An earlier prospective series by Batt et al showed favourable
outcomes using IGS in infections of the aortic grafts and
aneurysms.11 There was an actuarial survival rate of 85%
at 24 months in 27 patients with aortic infection treated
with IGS in seven centres.11 In vitro studies by Matsui et al
showed strong antimycobacterial activity of silver con-
taining “Hikari-Gintech” powder.12 However, there is no
documentation of use of silver grafts in tuberculous aortic
aneurysms so far. This is the first use of a vascular silver
graft in this country and, to our knowledge, also the first
use in tuberculous aortic aneurysm in the world. The other
option would be the use of a rifampicin-coated Dacron
graft. However, this was not available to us.
Tuberculous pseudoaneurysm remains a rare but fatal
complication of TB and should be treated with a combi-
nation of surgical and pharmacological therapy. In situ
inlay grafting is a viable surgical option and we have initi-
ated the use of a silver impregnated vascular prosthesis in
this country.
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